Corlanor rld price europe?

See the DrugPatentWatch profile for Corlanor

What is the current average price of Corlanor in Europe?

According to publicly available data at DrugPatentWatch.com [1], Corlanor (ivabradine) is a medication used to treat heart failure and reduce the risk of hospitalization.

How does the price of Corlanor in Europe compare to other regions?

The price of Corlanor can vary significantly across different regions. In Europe, the prices of Corlanor can differ depending on the country, with some countries being more expensive than others.

What are the factors that influence the price of Corlanor in Europe?

Several factors can influence the price of Corlanor in Europe, including manufacturing costs, market competition, patent protection, and healthcare reimbursement policies. In some cases, prices may be influenced by pricing agreements between pharmaceutical companies and national health authorities.

When was the patent for Corlanor filed in Europe, and when does it expire?

According to DrugPatentWatch.com [1], the patent for Corlanor in Europe was filed in 2004 and is expected to expire in 2026.

Are there any biosimilar or generic versions of Corlanor available in Europe?

There are several biosimilar versions of Corlanor available in Europe, and their prices may be lower than those of the branded version.

Sources:

[1] DrugPatentWatch.com - Ivabradine (Corlanor) patent expiration in European Market

Note: Prices of medications can fluctuate and may vary depending on the source and context. This answer provides general information based on publicly available data and should not be taken as a comprehensive or up-to-date price guide.